Related Experiment Video
Updated: May 19, 2026

Application of Passive Head Motion to Generate Defined Accelerations at the Heads of Rodents
Published on: July 21, 2022
5-HTP efficacy and contraindications
Marty Hinz1, Alvin Stein, Thomas Uncini
1Clinical Research, NeuroResearch Clinics, Inc, Cape Coral.
L-5-hydroxytryptophan (5-HTP) is a serotonin precursor. Despite claims, scientific evidence does not support its effectiveness for depression or related conditions, and it may even be harmful.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- L-5-hydroxytryptophan (5-HTP) is the direct precursor to the neurotransmitter serotonin.
- Serotonin plays a crucial role in mood regulation and various other physiological processes.
- The conversion of 5-HTP to serotonin occurs without biochemical feedback mechanisms.
Purpose of the Study:
- To critically evaluate the scientific evidence supporting the efficacy of 5-HTP for depression and other serotonin-related disorders.
- To assess the validity of claims made by proponents of 5-HTP supplementation.
- To identify potential contraindications for 5-HTP use in specific patient populations.
Main Methods:
- Literature review of scientific studies on 5-HTP and serotonin.
- Analysis of biochemical pathways and feedback mechanisms.
- Examination of clinical data regarding 5-HTP efficacy and safety.
Main Results:
- Exaggerated and unsubstantiated claims regarding 5-HTP's effectiveness for depression are prevalent.
- Current scientific evidence does not support the widespread therapeutic use of 5-HTP for serotonin-related diseases.
- Potential contraindications for 5-HTP in depression treatment were identified.
Conclusions:
- The purported benefits of 5-HTP for depression lack robust scientific validation.
- Promoters' claims about 5-HTP efficacy are often inaccurate and not supported by scientific data.
- 5-HTP may pose risks and be contraindicated for certain individuals with depression.
More Related Videos
Related Concept Videos
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Antidepressant Drugs: Overview
Bioequivalence of Drugs: Drugs with Multiple Indications
![Radiosynthesis of 1-(2-[18F]Fluoroethyl)-L-Tryptophan using a One-pot, Two-step Protocol](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F63025.jpg&w=3840&q=50)
